Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 211

1.

Upregulation of FOXM1 in a subset of relapsed myeloma results in poor outcome.

Gu C, Holman C, Sompallae R, Jing X, Tomasson M, Hose D, Seckinger A, Zhan F, Tricot G, Goldschmidt H, Yang Y, Janz S.

Blood Cancer J. 2018 Feb 15;8(2):22. doi: 10.1038/s41408-018-0060-0. No abstract available.

2.

High performance InAs/InP quantum dot 34.462-GHz C-band coherent comb laser module.

Lu ZG, Liu JR, Song CY, Weber J, Mao Y, Chang SD, Ding HP, Poole PJ, Barrios PJ, Poitras D, Janz S, O'Sullivan M.

Opt Express. 2018 Jan 22;26(2):2160-2167. doi: 10.1364/OE.26.002160.

PMID:
29401940
3.

Chromosomal instability and acquired drug resistance in multiple myeloma.

Wang W, Zhang Y, Chen R, Tian Z, Zhai Y, Janz S, Gu C, Yang Y.

Oncotarget. 2017 Sep 11;8(44):78234-78244. doi: 10.18632/oncotarget.20829. eCollection 2017 Sep 29. Review.

4.

Temperature dependence mitigation in stationary Fourier-transform on-chip spectrometers.

Herrero-Bermello A, Velasco AV, Podmore H, Cheben P, Schmid JH, Janz S, Calvo ML, Xu DX, Scott A, Corredera P.

Opt Lett. 2017 Jun 1;42(11):2239-2242. doi: 10.1364/OL.42.002239.

PMID:
28569891
5.

An Engineered Virus Library as a Resource for the Spectrum-wide Exploration of Virus and Vector Diversity.

Zhang W, Fu J, Liu J, Wang H, Schiwon M, Janz S, Schaffarczyk L, von der Goltz L, Ehrke-Schulz E, Dörner J, Solanki M, Boehme P, Bergmann T, Lieber A, Lauber C, Dahl A, Petzold A, Zhang Y, Stewart AF, Ehrhardt A.

Cell Rep. 2017 May 23;19(8):1698-1709. doi: 10.1016/j.celrep.2017.05.008.

6.

NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma.

Hao M, Franqui-Machin R, Xu H, Shaughnessy J Jr, Barlogie B, Roodman D, Quelle DE, Janz S, Tomasson MH, Sanderson RD, Qiu L, Frech I, Tricot G, Zhan F.

Leukemia. 2017 Jul;31(7):1648-1650. doi: 10.1038/leu.2017.115. Epub 2017 Apr 12. No abstract available.

7.

Transgenic mouse model of IgM+ lymphoproliferative disease mimicking Waldenström macroglobulinemia.

Tompkins VS, Sompallae R, Rosean TR, Walsh S, Acevedo M, Kovalchuk AL, Han SS, Jing X, Holman C, Rehg JE, Herms S, Sunderland JS, Morse HC, Janz S.

Blood Cancer J. 2016 Nov 4;6(11):e488. doi: 10.1038/bcj.2016.95.

8.

Utilizing a pH-Sensitive Dye in the Selective Fluorescent Recognition of Sulfate.

Agafontsev AM, Shumilova TA, Panchenko PA, Janz S, Fedorova OA, Kataev EA.

Chemistry. 2016 Oct 10;22(42):15069-15074. doi: 10.1002/chem.201602623. Epub 2016 Sep 5.

PMID:
27592858
9.

Single-etch subwavelength engineered fiber-chip grating couplers for 1.3 µm datacom wavelength band.

Benedikovic D, Alonso-Ramos C, Cheben P, Schmid JH, Wang S, Halir R, Ortega-Moñux A, Xu DX, Vivien L, Lapointe J, Janz S, Dado M.

Opt Express. 2016 Jun 13;24(12):12893-904. doi: 10.1364/OE.24.012893.

PMID:
27410309
10.

Mouse model of MYD88L265P-dependent DLBCL.

Janz S.

Blood. 2016 Jun 2;127(22):2660-1. doi: 10.1182/blood-2016-04-710434. No abstract available.

11.

PIAS1 Promotes Lymphomagenesis through MYC Upregulation.

Rabellino A, Melegari M, Tompkins VS, Chen W, Van Ness BG, Teruya-Feldstein J, Conacci-Sorrell M, Janz S, Scaglioni PP.

Cell Rep. 2016 Jun 7;15(10):2266-2278. doi: 10.1016/j.celrep.2016.05.015. Epub 2016 May 26.

12.

Fiber-chip edge coupler with large mode size for silicon photonic wire waveguides.

Papes M, Cheben P, Benedikovic D, Schmid JH, Pond J, Halir R, Ortega-Moñux A, Wangüemert-Pérez G, Ye WN, Xu DX, Janz S, Dado M, Vašinek V.

Opt Express. 2016 Mar 7;24(5):5026-5038. doi: 10.1364/OE.24.005026.

PMID:
29092331
13.

KSHV-encoded vIL-6 collaborates with deregulated c-Myc to drive plasmablastic neoplasms in mice.

Rosean TR, Holman CJ, Tompkins VS, Jing X, Krasowski MD, Rose-John S, Janz S.

Blood Cancer J. 2016 Feb 26;6:e398. doi: 10.1038/bcj.2016.6. No abstract available.

14.

FOXM1 is a therapeutic target for high-risk multiple myeloma.

Gu C, Yang Y, Sompallae R, Xu H, Tompkins VS, Holman C, Hose D, Goldschmidt H, Tricot G, Zhan F, Janz S.

Leukemia. 2016 Apr;30(4):873-82. doi: 10.1038/leu.2015.334. Epub 2015 Dec 9.

15.

Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?

Franqui-Machin R, Wendlandt EB, Janz S, Zhan F, Tricot G.

Oncotarget. 2015 Dec 1;6(38):40496-506. doi: 10.18632/oncotarget.5800. Review.

16.

High-directionality fiber-chip grating coupler with interleaved trenches and subwavelength index-matching structure.

Benedikovic D, Alonso-Ramos C, Cheben P, Schmid JH, Wang S, Xu DX, Lapointe J, Janz S, Halir R, Ortega-Moñux A, Wangüemert-Pérez JG, Molina-Fernández I, Fédéli JM, Vivien L, Dado M.

Opt Lett. 2015 Sep 15;40(18):4190-3. doi: 10.1364/OL.40.004190.

PMID:
26371893
17.

Subwavelength index engineered surface grating coupler with sub-decibel efficiency for 220-nm silicon-on-insulator waveguides.

Benedikovic D, Cheben P, Schmid JH, Xu DX, Lamontagne B, Wang S, Lapointe J, Halir R, Ortega-Moñux A, Janz S, Dado M.

Opt Express. 2015 Aug 24;23(17):22628-35. doi: 10.1364/OE.23.022628.

PMID:
26368230
18.

Broadband polarization independent nanophotonic coupler for silicon waveguides with ultra-high efficiency.

Cheben P, Schmid JH, Wang S, Xu DX, Vachon M, Janz S, Lapointe J, Painchaud Y, Picard MJ.

Opt Express. 2015 Aug 24;23(17):22553-63. doi: 10.1364/OE.23.022553.

PMID:
26368222
19.

Adoptive B-cell transfer mouse model of human myeloma.

Tompkins VS, Rosean TR, Holman CJ, DeHoedt C, Olivier AK, Duncan KM, Jing X, Foor SD, Acevedo MR, Walsh SA, Tricot G, Zhan F, Janz S.

Leukemia. 2016 Apr;30(4):962-6. doi: 10.1038/leu.2015.197. Epub 2015 Jul 23. No abstract available.

20.

RIP1 Cleavage in the Kinase Domain Regulates TRAIL-Induced NF-κB Activation and Lymphoma Survival.

Zhang L, Blackwell K, Workman LM, Chen S, Pope MR, Janz S, Habelhah H.

Mol Cell Biol. 2015 Oct;35(19):3324-38. doi: 10.1128/MCB.00692-15. Epub 2015 Jul 20.

21.

Structural parameters effect on the electrical and electroluminescence properties of silicon nanocrystals/SiO2 superlattices.

López-Vidrier J, Berencén Y, Hernández S, Mundet B, Gutsch S, Laube J, Hiller D, Löper P, Schnabel M, Janz S, Zacharias M, Garrido B.

Nanotechnology. 2015 May 8;26(18):185704. doi: 10.1088/0957-4484/26/18/185704. Epub 2015 Apr 15.

PMID:
25872562
22.

CDKN1A and FANCD2 are potential oncotargets in Burkitt lymphoma and multiple myeloma.

Han SS, Tompkins VS, Son DJ, Han S, Yun H, Kamberos NL, Dehoedt CL, Gu C, Holman C, Tricot G, Zhan F, Janz S.

Exp Hematol Oncol. 2015 Mar 27;4:9. doi: 10.1186/s40164-015-0005-2. eCollection 2015.

23.

Bruton tyrosine kinase is a therapeutic target in stem-like cells from multiple myeloma.

Yang Y, Shi J, Gu Z, Salama ME, Das S, Wendlandt E, Xu H, Huang J, Tao Y, Hao M, Franqui R, Levasseur D, Janz S, Tricot G, Zhan F.

Cancer Res. 2015 Feb 1;75(3):594-604. doi: 10.1158/0008-5472.CAN-14-2362. Epub 2015 Jan 14.

24.

NIAM-deficient mice are predisposed to the development of proliferative lesions including B-cell lymphomas.

Reed SM, Hagen J, Muniz VP, Rosean TR, Borcherding N, Sciegienka S, Goeken JA, Naumann PW, Zhang W, Tompkins VS, Janz S, Meyerholz DK, Quelle DE.

PLoS One. 2014 Nov 13;9(11):e112126. doi: 10.1371/journal.pone.0112126. eCollection 2014.

25.

The tumor microenvironment is the main source of IL-6 for plasma cell tumor development in mice.

Rosean TR, Tompkins VS, Olivier AK, Sompallae R, Norian LA, Morse HC 3rd, Waldschmidt TJ, Janz S.

Leukemia. 2015 Jan;29(1):233-7. doi: 10.1038/leu.2014.260. Epub 2014 Sep 3. No abstract available.

26.

NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma.

Yang Y, Zhou W, Xia J, Gu Z, Wendlandt E, Zhan X, Janz S, Tricot G, Zhan F.

Oncotarget. 2014 Dec 15;5(23):11986-97.

27.

Forkhead box M1 regulates quiescence-associated radioresistance of human head and neck squamous carcinoma cells.

Eckers JC, Kalen AL, Sarsour EH, Tompkins VS, Janz S, Son JM, Doskey CM, Buettner GR, Goswami PC.

Radiat Res. 2014 Oct;182(4):420-9. doi: 10.1667/RR13726.1. Epub 2014 Sep 17.

28.

Fabrication tolerant and broadband polarization splitter and rotator based on a taper-etched directional coupler.

Xiong Y, Xu DX, Schmid JH, Cheben P, Janz S, Ye WN.

Opt Express. 2014 Jul 14;22(14):17458-65. doi: 10.1364/OE.22.017458.

PMID:
25090559
29.

Preclinical validation of interleukin 6 as a therapeutic target in multiple myeloma.

Rosean TR, Tompkins VS, Tricot G, Holman CJ, Olivier AK, Zhan F, Janz S.

Immunol Res. 2014 Aug;59(1-3):188-202. doi: 10.1007/s12026-014-8528-x. Review.

30.

A new model of LMP1-MYC interaction in B cell lymphoma.

Ontiveros EP, Halwani A, Stunz LL, Kamberos N, Olivier AK, Janz S, Bishop GA.

Leuk Lymphoma. 2014 Dec;55(12):2917-23. doi: 10.3109/10428194.2014.900762. Epub 2014 Apr 23.

31.

ALDH1 activity identifies tumor-initiating cells and links to chromosomal instability signatures in multiple myeloma.

Zhou W, Yang Y, Gu Z, Wang H, Xia J, Wu X, Zhan X, Levasseur D, Zhou Y, Janz S, Tricot G, Shi J, Zhan F.

Leukemia. 2014 May;28(5):1155-8. doi: 10.1038/leu.2013.383. Epub 2013 Dec 24. No abstract available.

32.

(18)F-FDG-PET/CT imaging in an IL-6- and MYC-driven mouse model of human multiple myeloma affords objective evaluation of plasma cell tumor progression and therapeutic response to the proteasome inhibitor ixazomib.

Duncan K, Rosean TR, Tompkins VS, Olivier A, Sompallae R, Zhan F, Tricot G, Acevedo MR, Ponto LL, Walsh SA, Tygrett LT, Berger AJ, Waldschmidt T, Morse HC 3rd, Sunderland JJ, Janz S.

Blood Cancer J. 2013 Nov 29;3:e165. doi: 10.1038/bcj.2013.61.

33.

Identification of candidate B-lymphoma genes by cross-species gene expression profiling.

Tompkins VS, Han SS, Olivier A, Syrbu S, Bair T, Button A, Jacobus L, Wang Z, Lifton S, Raychaudhuri P, Morse HC 3rd, Weiner G, Link B, Smith BJ, Janz S.

PLoS One. 2013 Oct 9;8(10):e76889. doi: 10.1371/journal.pone.0076889. eCollection 2013.

34.
35.

Optical fiber interferometer array for scanless Fourier-transform spectroscopy.

Velasco AV, Cheben P, Florjańczyk M, Schmid JH, Bock PJ, Lapointe J, Delâge A, Janz S, Vachon M, Calvo ML, Xu DX, Civiš S.

Opt Lett. 2013 Jul 1;38(13):2262-4. doi: 10.1364/OL.38.002262.

PMID:
23811896
36.

Piperlongumine inhibits LMP1/MYC-dependent mouse B-lymphoma cells.

Han SS, Tompkins VS, Son DJ, Kamberos NL, Stunz LL, Halwani A, Bishop GA, Janz S.

Biochem Biophys Res Commun. 2013 Jul 12;436(4):660-5. doi: 10.1016/j.bbrc.2013.06.012. Epub 2013 Jun 11.

37.

Reduced CXCR4 expression is associated with extramedullary disease in a mouse model of myeloma and predicts poor survival in multiple myeloma patients treated with bortezomib.

Stessman HA, Mansoor A, Zhan F, Janz S, Linden MA, Baughn LB, Van Ness B.

Leukemia. 2013 Oct;27(10):2075-7. doi: 10.1038/leu.2013.148. Epub 2013 May 14. No abstract available.

38.

Profiling bortezomib resistance identifies secondary therapies in a mouse myeloma model.

Stessman HA, Baughn LB, Sarver A, Xia T, Deshpande R, Mansoor A, Walsh SA, Sunderland JJ, Dolloff NG, Linden MA, Zhan F, Janz S, Myers CL, Van Ness BG.

Mol Cancer Ther. 2013 Jun;12(6):1140-50. doi: 10.1158/1535-7163.MCT-12-1151. Epub 2013 Mar 27.

39.

Photonic wire biosensor microarray chip and instrumentation with application to serotyping of Escherichia coli isolates.

Janz S, Xu DX, Vachon M, Sabourin N, Cheben P, McIntosh H, Ding H, Wang S, Schmid JH, Delâge A, Lapointe J, Densmore A, Ma R, Sinclair W, Logan SM, Mackenzie R, Liu QY, Zhang D, Lopinski G, Mozenson O, Gilmour M, Tabor H.

Opt Express. 2013 Feb 25;21(4):4623-37. doi: 10.1364/OE.21.004623.

PMID:
23481995
40.

High-resolution Fourier-transform spectrometer chip with microphotonic silicon spiral waveguides.

Velasco AV, Cheben P, Bock PJ, Delâge A, Schmid JH, Lapointe J, Janz S, Calvo ML, Xu DX, Florjańczyk M, Vachon M.

Opt Lett. 2013 Mar 1;38(5):706-8. doi: 10.1364/OL.38.000706.

PMID:
23455272
41.

Piperlongumine inhibits proliferation and survival of Burkitt lymphoma in vitro.

Han SS, Son DJ, Yun H, Kamberos NL, Janz S.

Leuk Res. 2013 Feb;37(2):146-54. doi: 10.1016/j.leukres.2012.11.009. Epub 2012 Dec 10.

42.

Simultaneous retrieval of fluidic refractive index and surface adsorbed molecular film thickness using silicon wire waveguide biosensors.

Atsumi Y, Xu DX, Delâge A, Schmid JH, Vachon M, Cheben P, Janz S, Nishiyama N, Arai S.

Opt Express. 2012 Nov 19;20(24):26969-77. doi: 10.1364/OE.20.026969.

PMID:
23187552
43.

Athermal silicon waveguides with bridged subwavelength gratings for TE and TM polarizations.

Ibrahim M, Schmid JH, Aleali A, Cheben P, Lapointe J, Janz S, Bock PJ, Densmore A, Lamontagne B, Ma R, Xu DX, Ye WN.

Opt Express. 2012 Jul 30;20(16):18356-61. doi: 10.1364/OE.20.018356.

PMID:
23038386
44.

Demonstration of a curved sidewall grating demultiplexer on silicon.

Bock PJ, Cheben P, Schmid JH, Velasco AV, Delâge A, Janz S, Xu DX, Lapointe J, Hall TJ, Calvo ML.

Opt Express. 2012 Aug 27;20(18):19882-92. doi: 10.1364/OE.20.019882.

PMID:
23037040
45.

Highly tolerant tunable waveguide polarization rotator scheme.

Alonso-Ramos C, Halir R, Ortega-Moñux A, Cheben P, Vivien L, Molina-Fernández I, Marris-Morini D, Janz S, Xu DX, Schmid J.

Opt Lett. 2012 Sep 1;37(17):3534-6. doi: 10.1364/OL.37.003534.

PMID:
22940940
46.

The feed-forward loop between YB-1 and MYC is essential for multiple myeloma cell survival.

Bommert KS, Effenberger M, Leich E, Küspert M, Murphy D, Langer C, Moll R, Janz S, Mottok A, Weissbach S, Rosenwald A, Bargou R, Bommert K.

Leukemia. 2013 Feb;27(2):441-50. doi: 10.1038/leu.2012.185. Epub 2012 Jul 9.

47.

Characterization of ARF-BP1/HUWE1 interactions with CTCF, MYC, ARF and p53 in MYC-driven B cell neoplasms.

Qi CF, Kim YS, Xiang S, Abdullaev Z, Torrey TA, Janz S, Kovalchuk AL, Sun J, Chen D, Cho WC, Gu W, Morse HC 3rd.

Int J Mol Sci. 2012;13(5):6204-19. doi: 10.3390/ijms13056204. Epub 2012 May 21.

48.

Colorless directional coupler with dispersion engineered sub-wavelength structure.

Halir R, Maese-Novo A, Ortega-Moñux A, Molina-Fernández I, Wangüemert-Pérez JG, Cheben P, Xu DX, Schmid JH, Janz S.

Opt Express. 2012 Jun 4;20(12):13470-7. doi: 10.1364/OE.20.013470.

PMID:
22714374
49.

a membrane device for substrate-free photovoltaic characterization of quantum dot based p-i-n solar cells.

Löper P, Stüwe D, Künle M, Bivour M, Reichel C, Neubauer R, Schnabel M, Hermle M, Eibl O, Janz S, Zacharias M, Glunz SW.

Adv Mater. 2012 Jun 19;24(23):3124-9. doi: 10.1002/adma.201200539. Epub 2012 May 16. No abstract available.

PMID:
22588832
50.

HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice.

Suthaus J, Stuhlmann-Laeisz C, Tompkins VS, Rosean TR, Klapper W, Tosato G, Janz S, Scheller J, Rose-John S.

Blood. 2012 May 31;119(22):5173-81. doi: 10.1182/blood-2011-09-377705. Epub 2012 Apr 9.

Supplemental Content

Support Center